• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后 3 年死亡率预测:基于 7 项当代支架试验患者水平数据的更新逻辑临床 SYNTAX 评分。

Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials.

机构信息

Department of Interventional Cardiology, Thoraxcenter, Rotterdam, the Netherlands; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.

Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.

出版信息

JACC Cardiovasc Interv. 2014 May;7(5):464-70. doi: 10.1016/j.jcin.2014.02.007.

DOI:10.1016/j.jcin.2014.02.007
PMID:24852801
Abstract

OBJECTIVES

This study aimed to update the Logistic Clinical SYNTAX score to predict 3-year survival after percutaneous coronary intervention (PCI) and compare the performance with the SYNTAX score alone.

BACKGROUND

The SYNTAX score is a well-established angiographic tool to predict long-term outcomes after PCI. The Logistic Clinical SYNTAX score, developed by combining clinical variables with the anatomic SYNTAX score, has been shown to perform better than the SYNTAX score alone in predicting 1-year outcomes after PCI. However, the ability of this score to predict long-term survival is unknown.

METHODS

Patient-level data (N = 6,304, 399 deaths within 3 years) from 7 contemporary PCI trials were analyzed. We revised the overall risk and the predictor effects in the core model (SYNTAX score, age, creatinine clearance, and left ventricular ejection fraction) using Cox regression analysis to predict mortality at 3 years. We also updated the extended model by combining the core model with additional independent predictors of 3-year mortality (i.e., diabetes mellitus, peripheral vascular disease, and body mass index).

RESULTS

The revised Logistic Clinical SYNTAX models showed better discriminative ability than the anatomic SYNTAX score for the prediction of 3-year mortality after PCI (c-index: SYNTAX score, 0.61; core model, 0.71; and extended model, 0.73 in a cross-validation procedure). The extended model in particular performed better in differentiating low- and intermediate-risk groups.

CONCLUSIONS

Risk scores combining clinical characteristics with the anatomic SYNTAX score substantially better predict 3-year mortality than the SYNTAX score alone and should be used for long-term risk stratification of patients undergoing PCI.

摘要

目的

本研究旨在更新 Logistic 临床 SYNTAX 评分以预测经皮冠状动脉介入治疗(PCI)后 3 年的生存率,并与单独的 SYNTAX 评分进行比较。

背景

SYNTAX 评分是一种经过验证的用于预测 PCI 后长期预后的血管造影工具。Logistic 临床 SYNTAX 评分通过将临床变量与解剖 SYNTAX 评分相结合而开发,与单独的 SYNTAX 评分相比,其在预测 PCI 后 1 年结局方面表现更好。然而,该评分预测长期生存率的能力尚不清楚。

方法

对来自 7 项当代 PCI 试验的患者水平数据(N=6304 例,3 年内死亡 399 例)进行分析。我们使用 Cox 回归分析对核心模型(SYNTAX 评分、年龄、肌酐清除率和左心室射血分数)中的总体风险和预测因素效应进行修订,以预测 3 年内的死亡率。我们还通过将核心模型与 3 年死亡率的其他独立预测因素(即糖尿病、外周血管疾病和体重指数)相结合,对扩展模型进行了更新。

结果

修订后的 Logistic 临床 SYNTAX 模型在预测 PCI 后 3 年死亡率方面比解剖 SYNTAX 评分具有更好的区分能力(C 指数:SYNTAX 评分 0.61、核心模型 0.71、扩展模型 0.73 在交叉验证过程中)。扩展模型尤其在区分低危和中危组方面表现更好。

结论

将临床特征与解剖 SYNTAX 评分相结合的风险评分可显著更好地预测 3 年死亡率,优于单独的 SYNTAX 评分,应用于接受 PCI 的患者的长期风险分层。

相似文献

1
Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials.经皮冠状动脉介入治疗后 3 年死亡率预测:基于 7 项当代支架试验患者水平数据的更新逻辑临床 SYNTAX 评分。
JACC Cardiovasc Interv. 2014 May;7(5):464-70. doi: 10.1016/j.jcin.2014.02.007.
2
Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.经皮冠状动脉介入治疗的急性冠状动脉综合征患者 1 年死亡率预测:Logistic 临床 SYNTAX(紫杉醇与心脏手术联合经皮冠状动脉介入治疗的协同作用)评分的验证。
JACC Cardiovasc Interv. 2013 Jul;6(7):737-45. doi: 10.1016/j.jcin.2013.04.004.
3
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery.经皮冠状动脉介入治疗左主干冠状动脉患者的 logistic 临床 SYNTAX 评分对预测 1 年死亡率的有效性。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E446-52. doi: 10.1002/ccd.24944. Epub 2013 Jun 3.
4
Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.SYNTAX score-II 对 1528 例行左主干经皮冠状动脉介入治疗患者的长期预后能力的验证和比较。
JACC Cardiovasc Interv. 2014 Oct;7(10):1128-37. doi: 10.1016/j.jcin.2014.05.018. Epub 2014 Sep 17.
5
Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.经皮冠状动脉介入治疗后更新的 logistic 临床 SYNTAX 评分在既往冠状动脉旁路移植术患者中的应用价值:来自 GLOBAL LEADERS 试验的结果。
Catheter Cardiovasc Interv. 2020 Nov;96(5):E516-E526. doi: 10.1002/ccd.28898. Epub 2020 Apr 15.
6
The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.基于解剖和临床的 NERS(新风险分层)评分 II 预测无保护左主干冠状动脉疾病支架置入后的临床结局:来自多中心、前瞻性登记研究的结果。
JACC Cardiovasc Interv. 2013 Dec;6(12):1233-41. doi: 10.1016/j.jcin.2013.08.006. Epub 2013 Nov 13.
7
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.解剖学和临床特征指导个体患者冠状动脉旁路移植术与经皮冠状动脉介入治疗决策:SYNTAX 评分 II 的制定和验证。
Lancet. 2013 Feb 23;381(9867):639-50. doi: 10.1016/S0140-6736(13)60108-7.
8
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.通过左主干冠状动脉经皮冠状动脉介入治疗后残余 SYNTAX 评分的重复血管造影风险评估来客观化不完全血运重建的影响。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):333-40. doi: 10.1002/ccd.24642. Epub 2013 Apr 8.
9
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.在接受经皮或外科左主干血运重建的患者中,全球风险分类和临床 SYNTAX(经皮冠状动脉介入治疗与紫杉醇和心脏手术之间的协同作用)评分。
JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.
10
Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.将残余 SYNTAX 评分纳入其中,可提高经皮冠状动脉介入治疗患者的年龄、肌酐和射血分数(ACEF)评分对心源性死亡率的预测能力。
Catheter Cardiovasc Interv. 2020 Feb;95 Suppl 1:534-541. doi: 10.1002/ccd.28673. Epub 2019 Dec 26.

引用本文的文献

1
Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications.经皮冠状动脉介入治疗(PCI)后与硬终点相关的临床和血管特征及其联合预后意义。
J Am Heart Assoc. 2023 Sep 5;12(17):e030572. doi: 10.1161/JAHA.123.030572. Epub 2023 Aug 29.
2
Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations.药物洗脱支架(DES)相较于裸金属支架(BMS)在预防不同人群中心肌梗死、缺血性中风和死亡风险方面的优势。
J Clin Med. 2022 Dec 20;12(1):24. doi: 10.3390/jcm12010024.
3
The performance of SYNTAX score versus the coronary angiogram standard evaluation in the prediction of cardiovascular events in a cohort of patients with stable coronary heart disease.
在一组稳定型冠心病患者中,SYNTAX评分与冠状动脉造影标准评估在预测心血管事件方面的表现。
Cardiovasc Diagn Ther. 2022 Oct;12(5):563-576. doi: 10.21037/cdt-22-172.
4
Usefulness of the SYNTAX Score II to Predict In-Hospital and Long-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.SYNTAX评分II对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者院内及长期死亡率的预测价值
Sisli Etfal Hastan Tip Bul. 2022 Jun 28;56(2):182-188. doi: 10.14744/SEMB.2021.33410. eCollection 2022.
5
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.替格瑞洛单药治疗与药物洗脱冠状动脉支架置入术后 1 个月双联抗血小板治疗在 STEMI 患者中的对比:随机 GLOBAL LEADERS 试验的事后分析。
Eur Heart J Acute Cardiovasc Care. 2021 Oct 1;10(7):756-773. doi: 10.1093/ehjacc/zuab033.
6
Update and, internal and temporal-validation of the FRANCE-2 and ACC-TAVI early-mortality prediction models for Transcatheter Aortic Valve Implantation (TAVI) using data from the Netherlands heart registration (NHR).利用荷兰心脏注册(NHR)的数据,对用于经导管主动脉瓣植入术(TAVI)的FRANCE - 2和ACC - TAVI早期死亡率预测模型进行更新、内部及时间验证。
Int J Cardiol Heart Vasc. 2021 Jan 23;32:100716. doi: 10.1016/j.ijcha.2021.100716. eCollection 2021 Feb.
7
A fitting machine learning prediction model for short-term mortality following percutaneous catheterization intervention: a nationwide population-based study.经皮导管介入术后短期死亡率的合适机器学习预测模型:一项基于全国人群的研究。
Ann Transl Med. 2019 Dec;7(23):732. doi: 10.21037/atm.2019.12.21.
8
Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program.退伍军人事务部临床评估报告和跟踪计划中,经皮或手术血运重建后冠状动脉解剖复杂性与临床结局的关系。
JAMA Cardiol. 2019 Aug 1;4(8):727-735. doi: 10.1001/jamacardio.2019.1923.
9
Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer population.在所有患者人群中,SYNTAX评分对经皮冠状动脉介入治疗后长期死亡率的年龄依赖性影响。
J Geriatr Cardiol. 2018 Sep 28;15(9):559-566. doi: 10.11909/j.issn.1671-5411.2018.09.009.
10
Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention.用于预测经皮冠状动脉介入治疗后死亡率的临床风险评分的开发与验证
Open Heart. 2017 Jul 25;4(2):e000576. doi: 10.1136/openhrt-2016-000576. eCollection 2017.